Avelumab is an IgG1-type monoclonal antibody, which also has antibody-dependent cell-mediated cytotoxic effects compared to other PD-L1 inhibitors, causing direct lysis of tumor cells (44). This evidence concerns the gene CD274 and neoplasm.